Paper23364441
Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
French MA and 9 others. AIDS, 2013. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. Papers, record 23364441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23364441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptive Immunity | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| HIV Seropositivity | Major topic |
| Immunoglobulin G | Major topic |
| Killer Cells, Natural | Major topic |
| Lymphocyte Activation | Major topic |
| gag Gene Products, Human Immunodeficiency Virus | Major topic |
| Alleles | |
| Blotting, Western | |
| Disease Progression | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Host-Pathogen Interactions | |
| Humans | |
| Male | |
| RNA, Viral | |
| Receptors, IgG | |
| Viral Load | |
| Virus Replication |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39288118 | Identification of antibody targets associated with lower HIV viral load and viremic control. | PLoS One | 2024 | https://conductscience.org/library/papers/39288118 | PubMed |
| 34717659 | Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features. | Retrovirology | 2021 | https://conductscience.org/library/papers/34717659 | PubMed |
| 33328567 | Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques. | Sci Rep | 2020 | https://conductscience.org/library/papers/33328567 | PubMed |
| 32733445 | Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women. | Front Immunol | 2020 | https://conductscience.org/library/papers/32733445 | PubMed |
| 31048360 | Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection. | Mol Syst Biol | 2019 | https://conductscience.org/library/papers/31048360 | PubMed |
| 30952887 | Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques. | Sci Rep | 2019 | https://conductscience.org/library/papers/30952887 | PubMed |
| 30534128 | Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection. | Front Immunol | 2018 | https://conductscience.org/library/papers/30534128 | PubMed |
| 30153293 | Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. | PLoS One | 2018 | https://conductscience.org/library/papers/30153293 | PubMed |
| 29794117 | Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity. | J Exp Med | 2018 | https://conductscience.org/library/papers/29794117 | PubMed |
| 29630668 | HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/29630668 | PubMed |
| 29581149 | High-resolution definition of humoral immune response correlates of effective immunity against HIV. | Mol Syst Biol | 2018 | https://conductscience.org/library/papers/29581149 | PubMed |
| 29560282 | Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ. | NPJ Vaccines | 2018 | https://conductscience.org/library/papers/29560282 | PubMed |
| 29326728 | Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination. | Front Immunol | 2017 | https://conductscience.org/library/papers/29326728 | PubMed |
| 28830571 | Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. | Retrovirology | 2017 | https://conductscience.org/library/papers/28830571 | PubMed |
| 28725225 | Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design. | Front Immunol | 2017 | https://conductscience.org/library/papers/28725225 | PubMed |
| 28629910 | Memory B Cells, the HLA-B*57 Allele and Natural Control of HIV Infection. | EBioMedicine | 2017 | https://conductscience.org/library/papers/28629910 | PubMed |
| 28615147 | HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection. | EBioMedicine | 2017 | https://conductscience.org/library/papers/28615147 | PubMed |
| 28604502 | Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers. | J Acquir Immune Defic Syndr | 2017 | https://conductscience.org/library/papers/28604502 | PubMed |
| 26813340 | Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel. | Mucosal Immunol | 2016 | https://conductscience.org/library/papers/26813340 | PubMed |
| 26433697 | Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents? | Trends Microbiol | 2015 | https://conductscience.org/library/papers/26433697 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARL6 | 84100 | PubTator's text mining | https://conductscience.org/library/genes/84100 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FCGR2A | 2212 | PubTator's text mining | https://conductscience.org/library/genes/2212 | NCBI Gene |
| H3P12 | 100689229 | PubTator's text mining | https://conductscience.org/library/genes/100689229 | NCBI Gene |
| H3P44 | 347376 | PubTator's text mining | https://conductscience.org/library/genes/347376 | NCBI Gene |
| HCP5 | 10866 | PubTator's text mining | https://conductscience.org/library/genes/10866 | NCBI Gene |
| HLA-B | 3106 | PubTator's text mining | https://conductscience.org/library/genes/3106 | NCBI Gene |
| POLD3 | 10714 | PubTator's text mining | https://conductscience.org/library/genes/10714 | NCBI Gene |
| TMED2 | 10959 | PubTator's text mining | https://conductscience.org/library/genes/10959 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23364441
GET https://conductscience.org/api/papers/v1/23364441/cited_by?page=2